George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDDDD.L Regulatory News (DDDD)

  • There is currently no data for DDDD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Meeting

9 Mar 2020 11:07

RNS Number : 4455F
4d Pharma PLC
09 March 2020
 

4D pharma plc

 

("4D pharma" or the "Company")

 

Result of General Meeting

 

4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of live biotherapeutic products, announces that, at the General Meeting held earlier today to enable the proposed issue of a total of 44,000,000 New Ordinary Shares in connection with the Placing and Subscription to raise gross proceeds of £22 million, all Resolutions were duly passed.

 

Further to the Result of Placing announcement made on 18 February 2020, 27,176,920 Subscription Shares and 16,823,080 Placing Shares will be issued. The total number of New Ordinary Shares to be issued pursuant to the Subscription and Placing remains unchanged.

Application has been made to the London Stock Exchange for the 44,000,000 New Ordinary Shares to be admitted to trading on AIM and it is expected that Admission will occur and dealings commence at 8.00 a.m. tomorrow, 10 March 2020.

Total Voting Rights

Following Admission, the Company will have 109,493,842 Ordinary Shares in issue. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules. There Company holds no Ordinary Shares in treasury.

Block Admission

A block admission has been made in respect of 22,000,000 shares which may arise from the exercise of Warrants issued in connection with the Fundraising ("Warrant Shares") under the scheme name '4D March 2020 Warrants'. Admission of the block listed shares will also take effect on 10 March 2020. For the avoidance of doubt, the Warrants themselves will not be admitted to Trading on AIM. Each Warrant entitles the holder to subscribe for one Ordinary Share at a price of 100 pence at any time up to 10 March 2025.

 

Definitions

 

Capitalised terms used in this announcement shall, unless defined in this announcement or unless the context provides otherwise, bear the same meaning ascribed to them in the announcement made by the Company on 18 February 2020 to announce the launch of the Placing.

 

 

For further information please contact:

4D

 

Duncan Peyton, Chief Executive Officer

ir@4dpharmaplc.com

+ 44 (0)113 895 0130

 

 

N+1 Singer - Nominated Adviser, Joint Bookrunner and Joint Broker

+44 (0) 20 7496 3000

Aubrey Powell / Justin McKeegan / Alex Bond (Corporate Finance)

Tom Salvesen (Corporate Broking)

 

 

Bryan Garnier & Co. Limited - Joint Bookrunner and Joint Broker

+44 (0)20 7332 2500

Dominic Wilson / Phil Walker

 

Chardan - US Placing Agent

David Lederman (Equity Capital Markets)

+1 646 465-9011

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ROMJLMBTMTMMBFM
Date   Source Headline
19th Jul 20167:00 amRNSClinical Update
10th Jun 20167:00 amRNSClinical Update
23rd May 20164:40 pmRNSSecond Price Monitoring Extn
23rd May 20164:35 pmRNSPrice Monitoring Extension
23rd May 20162:35 pmRNSResult of AGM
23rd May 20167:00 amRNSClinical Update
22nd Apr 201610:49 amRNSAnnual Report and Notice of AGM
8th Apr 20167:00 amRNSAcquisition
31st Mar 20167:00 amRNSFinal Results
29th Feb 20164:40 pmRNSSecond Price Monitoring Extn
29th Feb 20164:35 pmRNSPrice Monitoring Extension
26th Feb 20167:00 amRNSClinical Update
11th Feb 20164:40 pmRNSSecond Price Monitoring Extn
11th Feb 20164:35 pmRNSPrice Monitoring Extension
10th Feb 20167:00 amRNSAcquisition
22nd Jan 20167:00 amRNSChange of Registered Office
19th Jan 20167:00 amRNSClinical Update
4th Jan 20169:04 amRNSHolding(s) in Company
21st Dec 20153:44 pmRNSHolding(s) in Company
17th Dec 201510:21 amRNSHolding(s) in Company
17th Dec 201510:17 amRNSHolding(s) in Company
11th Dec 20152:37 pmRNSHolding(s) in Company
11th Dec 20152:37 pmRNSHolding(s) in Company
11th Dec 20152:33 pmRNSHolding(s) in Company
8th Dec 20157:00 amRNSPlacing
3rd Dec 201512:38 pmRNSHolding(s) in Company
26th Nov 20157:00 amRNSResearch Update on MicroRx Discovery Platform
11th Nov 20157:00 amRNSClinical Trial Update
13th Oct 20157:00 amRNSHolding(s) in Company
30th Sep 20159:09 amRNSHolding(s) in Company
29th Sep 20157:00 amRNSInterim results for the period ended 30 June 2015
21st Aug 20157:00 amRNSClinical Trial Update
7th Aug 20157:00 amRNSResearch Collaboration
29th Jun 201510:56 amRNSResult of AGM
23rd Jun 20157:00 amRNSHolding(s) in Company
16th Jun 20157:00 amRNSResearch Update
5th Jun 20157:00 amRNSFinal Results
20th May 20157:00 amRNSResearch Update
22nd Apr 20152:48 pmRNSHolding(s) in Company
1st Apr 201510:53 amRNSHolding(s) in Company
30th Mar 20153:47 pmRNSAcquisition of minority interests
11th Feb 20153:38 pmRNSHolding(s) in Company
11th Feb 20152:28 pmRNSHolding(s) in Company
10th Feb 20154:04 pmRNSHolding(s) in Company
9th Feb 201510:17 amRNSResult of general meeting
21st Jan 20157:00 amRNSPlacing
7th Jan 20157:00 amRNSResearch Update
5th Jan 20157:00 amRNSResearch Update
6th Nov 20149:19 amRNSHolding(s) in Company
3rd Oct 201410:53 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.